Identification | Back Directory | [Name]
N-[5-(2,2-Difluoroethoxy)-3-pyridyl]-N-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-thiazolyl]methyl]ethanesulfonamide | [CAS]
2653255-56-0 | [Synonyms]
N-[5-(2,2-Difluoroethoxy)-3-pyridyl]-N-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-thiazolyl]methyl]ethanesulfonamide N-[5-(2,2-difluoroethoxy)-3-pyridyl]-N-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]thiazol-2-yl]methyl]ethanesulfonamide Ethanesulfonamide, N-[5-(2,2-difluoroethoxy)-3-pyridinyl]-N-[[5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-thiazolyl]methyl]- | [Molecular Formula]
C16H15F4N5O4S2 | [MOL File]
2653255-56-0.mol | [Molecular Weight]
481.45 |
Chemical Properties | Back Directory | [Boiling point ]
617.1±65.0 °C(predicted) | [density ]
1.524±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | [pka]
1.49±0.10(predicted) |
Hazard Information | Back Directory | [Uses]
HDAC6-IN-39 (Compound I-132) is an inhibitor for HDAC6 with IC50 of 0.0096 μM[1]. | [IC 50]
HDAC6: 0.0096 μM (IC50) | [References]
[1] MANDEGAR MA, et al., Hdac6 inhibitors for use in the treatment of dilated cardiomyopathy. WO2022226388. |
|
|